tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Medpace Holdings Amends Credit Facility with PNC Bank

Story Highlights
Medpace Holdings Amends Credit Facility with PNC Bank

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Medpace Holdings ( (MEDP) ) has provided an announcement.

On July 17, 2025, Medpace Holdings, Inc. announced an amendment to its unsecured credit facility with PNC Bank, increasing the line of credit to $10 million. For the second quarter of 2025, Medpace reported a 14.2% increase in revenue to $603.3 million and a 16.2% rise in EBITDA to $130.5 million compared to the previous year. The company also repurchased shares worth $518.5 million during the quarter. Despite a slight decrease in backlog, Medpace’s financial results reflect strong growth and operational efficiency, positioning it well within the industry.

The most recent analyst rating on (MEDP) stock is a Hold with a $345.00 price target. To see the full list of analyst forecasts on Medpace Holdings stock, see the MEDP Stock Forecast page.

Spark’s Take on MEDP Stock

According to Spark, TipRanks’ AI Analyst, MEDP is a Outperform.

Medpace Holdings scores well due to strong financial performance and cash flow generation. However, technical analysis indicates a neutral trend, and valuation metrics suggest the stock is fairly priced. The earnings call highlights both growth and challenges, warranting cautious optimism.

To see Spark’s full report on MEDP stock, click here.

More about Medpace Holdings

Medpace Holdings, Inc. is a global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company focuses on accelerating the global development of medical therapeutics through a high-science and disciplined operating approach, leveraging expertise in areas such as oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,000 people across 44 countries as of June 30, 2025.

Average Trading Volume: 418,548

Technical Sentiment Signal: Hold

Current Market Cap: $8.96B

For a thorough assessment of MEDP stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1